We are very lucky to have the opportunity to add Dr. Richard Calderone, Ph.D. to our Advisory Board. Dr. Richard Calderone is Professor & Chairman of the Department of Microbiology & Immunology. Director of the M.S. program in Biomedical Science Policy & Advocacy. He received his Ph.D. from West Virginia University in 1970 and has been at Georgetown University since 1974. Dr. Calderone is an expert in both microbiology and biomedical science policy. He runs the M.S. program in Biomedical Science Policy & Advocacy where he helps to create the next generation of biomedical policy makers and advocates. The focus of his research is on the two most common fungal pathogens of immunocompromised patients, Candida albicans and Aspergillus fumigatus. He uses molecular biological and biochemical approaches to identify new targets on these fungi that can be exploited in drug discovery. In this regard, the potential drug targets that have been identified are two-component signal transduction proteins. In addition, in C. albicans, he studies DNA repair and again focus upon identifying unique proteins that may have potential as drug targets. His lab’s collaboration with a medicinal chemist has resulted in 4 compounds in patent that we hope to further develop. The lab is supported by NIH funds and the research staff in the lab currently includes 2 PhD students and 2 research Assistant Professors and a post-doctoral fellow.